Skip to main content
. Author manuscript; available in PMC: 2017 Oct 25.
Published in final edited form as: Chem Biol Interact. 2016 Aug 16;258:21–29. doi: 10.1016/j.cbi.2016.08.010

Figure 1.

Figure 1

Effect of epigenetic inhibitors and chemotherapeutics on prostate cancer and kidney cytotoxicity. Cells were treated with 5-Aza (A), TSA (B), docetaxel (C) or CFZ (D) for 48 hr and cytotoxicity was assessed using MTT staining. Data are indicative of results from at least 6 separate passages per cell line (n ≥ 6) and are expressed as mean ± SD. (* p < 0.05 compared to respective control by One-way ANOVA followed by Bonferonni post-hoc test)